The FDA has scheduled an Oct. 15 meeting of its advisory committee to discuss whether to grant authorization for a booster dose of the J&J vaccine.
admin, , HEALTH & FITNESS, 0
Related Articles
Eli Lilly’s tirzepatide cuts heart failure risks, company says
Eli Lilly’s drug tirzepatide, sold under the names Mounjaro for diabetes and Zepbound for weight loss, improved symptoms in...
How bad will the flu be? Here’s what to know ahead of an unpredictable season
After a rough, record-setting flu season, doctors and health officials are bracing for another wave of fever, misery and...
U.S. life expectancy drops by ‘horrific’ amount during pandemic
Average life expectancy in the United States plummeted in 2020, widening the life expectancy gap between the U.S. and...
Trump administration asks for emergency pause on judge’s order to fully fund SNAP
The Trump administration told states on Friday that it will immediately begin funding SNAP benefits in full while its...
Even cautious Covid experts are starting to lower their guard as Biden urges return to normal
In recent weeks, governors across the United States, officials at the Centers for Disease Control and Prevention and even...
Who is getting vaccinated in the U.S.? Demand has all but collapsed in some areas
A handwritten log kept by nurses tells the story of the losing battle to get more people vaccinated against...
CDC expected to alert doctors about fake Botox
The Centers for Disease Control and Prevention is poised to alert doctors nationwide about fake Botox injections that have...
Start TODAY’s Stephanie Mansour Answers Member’s Questions
IE 11 is not supported. For an optimal experience visit our site on another browser. Oct. 27, 202504:44 Now...
